Stifel Financial’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.52K | Sell |
|
|||||
|
2025
Q1 | $5.21K | Hold |
|
|||||
|
2024
Q4 | $14.3K | Sell |
|
|||||
|
2024
Q3 | $26.2K | Hold |
|
|||||
|
2024
Q2 | $26.9K | Buy |
|
|||||
|
2024
Q1 | $37.6K | Sell |
|
|||||
|
2023
Q4 | $21.6K | Sell |
|
|||||
|
2023
Q3 | $23.3K | Hold |
|
|||||
|
2023
Q2 | $27.6K | Hold |
|
|||||
|
2023
Q1 | $32.5K | Sell |
|
|||||
|
2022
Q4 | $44.8K | Buy |
|
|||||
|
2022
Q3 | $32K | Sell |
|
|||||
|
2022
Q2 | $50K | Hold |
|
|||||
|
2022
Q1 | $61K | Sell |
|
|||||
|
2021
Q4 | $143K | Sell |
|
|||||
|
2021
Q3 | $229K | Buy |
|
|||||
|
2021
Q2 | $185K | Buy |
|
|||||
|
2021
Q1 | $178K | Buy |
|
|||||
|
2020
Q4 | $165K | Sell |
|
|||||
|
2020
Q3 | $1.33M | Buy |
|
|||||
|
2020
Q2 | $154K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.22M | Buy |
|